Related by context. All words. (Click for frequent words.) 67 CC genotype 66 genotype 65 homozygous 65 haplotypes 64 SNPs 64 heterozygous 63 proband 63 haplotype 63 genotypes 63 nondiabetic 63 seronegative 62 rs# [002] 62 rs# [003] 62 heterozygotes 61 MYH9 gene 61 allele frequencies 61 genotypic 61 HLA DQ2 61 polymorphisms 60 C#Y 60 exomes 60 #q# [001] 60 microdeletions 60 rs# [001] 60 microsatellite markers 60 rs# [004] 60 genetic markers 60 single nucleotide polymorphism 60 serum samples 60 rs# rs# 60 CNVs 60 haplogroups 60 variant allele 60 MLH1 60 SNP rs# [001] 60 Genotypes 59 HCV infected 59 loci 59 IL#B 59 MTHFR 59 missense mutations 59 transfected 59 T2DM 59 TT genotype 59 differentially expressed 59 BCG vaccinated 58 mitochondrial DNA mtDNA 58 mutated K ras 58 HIV uninfected 58 seropositivity 58 germline mutations 58 orthologs 58 probands 58 GSTP1 58 CDKN2A 58 coinfected 58 VNTR 58 hypercholesterolemic 58 MSH2 58 gene expression profiles 58 genotyping 58 promoter methylation 58 CCR5 delta# 58 microarray experiments 58 allelic variants 57 EGFR mutations 57 mtDNA 57 homozygotes 57 hypermethylated 57 homozygosity 57 mutant allele 57 activating mutation 57 sporadic ALS 57 haplogroup 57 variant alleles 57 #S rRNA 57 HBsAg 57 chromosome #q# [001] 57 NNRTI resistance 57 autosomal 57 syngeneic 57 polymorphism 57 alleles 57 heterozygote 57 allele 57 JAK2 V#F 57 SNP arrays 57 Haplogroup 56 Genotype 56 Prostate Lung Colorectal 56 PCR RFLP 56 PCa 56 ABCB1 56 HLA B 56 linkage disequilibrium 56 GSTM1 56 n = 56 breast cancer genes BRCA1 56 #p# [001] 56 HNPCC 56 Ashkenazi Jewish 56 PRNP 56 cagA 56 BRCA2 mutations 56 experimentally infected 56 kDa protein 56 BRAF V#E 56 genomewide 56 VKORC1 56 normotensive 56 K ras mutations 56 HLA DRB1 * 56 ErbB2 positive 56 BRCA1 mutations 56 heterozygosity 56 KRAS mutations 56 orthologous 56 HBeAg negative 56 MetS 56 papillary renal cell carcinoma 56 HMGA1 56 DQB1 * 56 phylogenetic analyzes 56 inbred strains 56 allelic 56 hyperlipidemic 56 APOE e4 56 adiponectin concentrations 56 PTPN# 56 immunocompetent 56 HLA A2 56 indels 56 LRRK2 gene 55 K#R [002] 55 HLA B# 55 TACI mutations 55 clinico pathological 55 IgA deficiency 55 Genotypic 55 serologic 55 DRD2 55 telomere lengths 55 HLA DR4 immune 55 HBeAg positive 55 HLA DR 55 deleterious mutation 55 paternally inherited 55 gene polymorphism 55 #q# deletion 55 hepatocellular carcinomas 55 frameshift mutation 55 APOL1 55 familial pancreatic cancer 55 KRAS wild 55 genetic loci 55 BARD1 55 chromosome #q# [002] 55 MC1R gene 55 BRCA2 mutation 55 genetic variants 55 prostate carcinoma 55 CDH1 55 undergone radical prostatectomy 55 viremic 55 breast carcinoma 55 BRCA mutation 55 BRAF V#E mutation 55 causative mutation 55 lamivudine resistant 55 Bos taurus 55 seroconverted 55 penetrance 55 ZNF# 55 #p# [003] 55 chromosome #p# [001] 55 HNSCC 55 normal karyotype 55 PIK3CA 55 FLT3 55 SCN5A 55 BeadChip 55 mRNA expression 55 variant rs# 55 NHANES III 54 T2D 54 genomic loci 54 male Wistar rats 54 autism susceptibility genes 54 mutation 54 gene variants 54 aged ≥ 54 sequence homology 54 homozygote 54 TRAF1 C5 54 advanced neoplasia 54 nondemented 54 PALB2 54 CFTR gene mutations 54 generalized vitiligo 54 CagA 54 ERBB2 54 IL#R 54 lymphoblastoid cell lines 54 CD3 + 54 Wwox 54 retrospective cohort 54 M. genitalium 54 BRCA2 gene mutation 54 C#BL/#J 54 peripheral blood mononuclear 54 CCL#L# 54 PCR amplified 54 HPV genotypes 54 cytogenetic 54 autosomal dominant 54 genetic polymorphisms 54 NRTI resistance 54 HIV seronegative 54 genetic variants associated 54 NSCLC tumors 54 SNP rs# [002] 54 GRK5 54 MHC genes 54 K ras 54 phenotype 54 genes predisposing 54 colorectal neoplasia 54 breast carcinomas 54 familial ALS 54 heritable traits 54 GBA mutations 54 dbSNP 54 CHEK2 54 gene polymorphisms 54 LQTS 54 chromosomal regions 54 plasma folate 54 non mutated KRAS 54 transcriptome sequencing 54 Y chromosomal 54 histologically confirmed 54 missense 54 #S rRNA gene 54 dopamine transporter gene 54 HCV genotype 54 differentially regulated 54 susceptibility loci 54 HLA loci 53 rheumatoid factor 53 splice variants 53 Genetics Consortium 53 mitochondrial genomes 53 HLA genes 53 c KIT 53 multivariate Cox 53 sequenced genomes 53 chromosome #q 53 ApoE gene 53 chromosome #q#.# [001] 53 HER2 expression 53 downregulated 53 lung adenocarcinoma 53 5 HTTLPR 53 genotypic resistance 53 UGT#A# * 53 subtype 53 nucleotide sequence 53 HLA DRB1 53 PTEN mutations 53 surgically resected 53 immunohistochemical 53 outbred 53 intronic 53 bivariate analyzes 53 mitochondrial genome 53 colorectal carcinoma 53 retrospectively analyzed 53 C#BL 6 mice 53 CYP# [002] 53 hypermethylation 53 C#BL 6 53 Human SNP Array 53 miRNA expression 53 BRCA1 BRCA2 53 virus HBV 53 clade B 53 HLA DR4 53 thrombophilia 53 inherited mutations 53 genotype 1a 53 methylation patterns 53 NPM1 gene 53 subtyped 53 Cytogenetic 53 HGPIN 53 transduced 53 Genotyping 53 HLA DR2 53 BRAF mutation 53 Sprague Dawley rats 53 qRT PCR 53 BRCA mutations 53 CYP#C# [002] 53 Wellcome Trust Case 53 underwent radical prostatectomy 53 noncarriers 53 genes encoding 53 International HapMap Project 53 hydroxyvitamin D levels 53 #q# [002] 53 basal cell carcinoma BCC 53 HLA markers 53 genes CYP#C# 53 undetectable HBV DNA 53 RASSF1A 53 COL#A# 53 confidence interval #.#-#.# 53 kilobase 53 K RAS 53 unmethylated 53 RRM1 53 functional polymorphism 53 gene locus 53 ortholog 53 advanced adenomas 53 GSTT1 53 mRNA transcripts 52 monozygotic twins 52 hepatoma 52 APOC3 52 IKZF1 52 situ hybridization 52 quantitative PCR 52 FLT3 mutations 52 TCF#L# gene 52 pg ml 52 MYH9 52 cynomolgus macaques 52 coding genes 52 K#N 52 prostate cancer CaP 52 microRNA expression 52 mutations 52 genetic variant 52 controlled dose escalation 52 TOP2A 52 μmol L 52 abnormal cytology 52 Polymorphism 52 gene loci 52 FLT3 ITD 52 prion gene 52 quantitative RT PCR 52 HIV HCV coinfected 52 UGT#A# 52 NPM1 mutations 52 KRAS oncogene 52 sequenced 52 glioma tumors 52 gene expression microarrays 52 EGFR gene 52 Leydig cell 52 logistic regression analysis 52 intergenic 52 osteosarcomas 52 STAT4 52 immunostaining 52 #q#.# [001] 52 IPAH 52 LHRH receptor positive 52 prospective cohort 52 CaP 52 APOE gene 52 monoinfected 52 medulloblastomas 52 immunized mice 52 euthyroid 52 TCF#L# 52 BAC clones 52 BeadChips 52 TP# mutation 52 BRCA1 mutation 52 TMEM#B 52 exome 52 gene amplification 52 seropositive 52 LPA gene 52 nonmetastatic 52 MBq 52 amplicons 52 pancreatic adenocarcinoma 52 assay detects 52 differentially expressed genes 52 phenotypic 52 NF1 52 monogenic 52 R#W [002] 52 genomewide association study 52 DRD4 52 SORT OUT III 52 gene expression patterns 52 ADPKD 52 maternally inherited 52 breast cancer subtypes 52 MDA MB 52 cancerous prostates removed 52 cM 52 phenotypically 52 MC1R 52 basal cell nevus syndrome 52 genetic variations 52 apolipoprotein E gene 52 CpG island 52 HPV# 52 untreated metastatic melanoma 52 colorectal tumor 52 XLHED 52 CYP#D# gene 52 KIF6 gene 52 cognitively normal 52 Illumina genotyping 52 STK# gene 52 gene variant 52 upregulated 52 underwent surgical resection 52 genomes 52 immunoreactive 52 GSTM1 gene 52 ADRB2 52 ovariectomized 52 KRAS mutations occur 52 somatic mutations 52 TMPRSS2 ERG 52 Single Nucleotide Polymorphism 52 gene expression 52 castrate resistant 52 germline mutation 52 A. thaliana 52 ceftazidime 51 Xenopus 51 nucleotide substitutions 51 antithymocyte globulin 51 CIN2 + 51 dizygotic 51 microcephalin 51 genotyping arrays 51 APOE ε4 51 observational cohort study 51 monozygotic 51 Communities ARIC study 51 prospectively evaluated 51 narcolepsy cataplexy 51 orthologous genes 51 collected saliva samples 51 immunohistochemical staining 51 CISH 51 Ovarian PLCO Cancer 51 Leukemias 51 advanced adenoma 51 allele frequency 51 multicentric 51 multiple logistic regression 51 chromosome #p# [002] 51 transcriptomes 51 polyomavirus 51 single nucleotide polymorphisms 51 KCNQ1 51 HBV genotype 51 human leukocyte antigen 51 transcriptome 51 Her2/neu 51 operable breast cancer 51 thyroid carcinoma 51 adenocarcinomas 51 bacterial isolates 51 NAFLD 51 #q#.# [002] 51 V Leiden 51 AML MDS 51 cDNA microarray 51 microsatellite instability 51 Polymorphisms 51 multivariate analysis 51 cDNA libraries 51 fasting glucose 51 TOMM# 51 distant metastasis 51 autosomal recessive 51 transgenic mice 51 constitutively expressed 51 brucei 51 PCA3 51 adenoma 51 VIPR2 51 IgG1 51 fasting glucose levels 51 phenotypes 51 underexpressed 51 glucose intolerant 51 G allele 51 hereditary hemochromatosis 51 mutant alleles 51 microdeletion 51 tumor histology 51 colorectal adenoma 51 amino acid sequences 51 microsatellite loci 51 transgenic rats 51 sCJD 51 mg q#h 51 pT3 51 essential thrombocythemia 51 Haplotype 51 histocompatibility 51 HER2 overexpression 51 BRCA2 mutation carriers 51 MRSA isolates 51 Asymptomatic 51 colorectal carcinomas 51 mtDNA sequence 51 serologically 51 imprinted genes 51 nonobese 51 TMPRSS2 ERG fusion 51 subfamilies 51 metabolomic profiles 51 APTIMA HPV 51 prostate adenocarcinoma 51 Haptoglobin 51 APOE e4 gene 51 missense mutation 51 Median survival 51 genetic variation 51 male Sprague Dawley 51 gene mutation 51 coding exons 51 estrogen receptor ER 51 unmutated 51 Cowden syndrome 51 median CD4 51 subfamily 51 HER2 amplification 51 replicon 51 genetic ancestry 51 ChIP chip 51 ascending doses 51 glutamic acid decarboxylase 51 ENPP1 51 miRview ™ squamous 51 genes differentially expressed 51 atypical hyperplasia 51 HLA typing 51 KRAS mutation 51 CYP#D# 51 ORMDL3 51 Immunohistochemical analysis 51 GenBank accession 51 serogroup 51 premenopausal 51 NPM1 51 EGFP 51 methylated DNA 51 HCV replicon 51 miR #a [001] 51 seroprevalence 51 BRCA mutation carriers 51 primordial germ cells 51 genetically divergent 51 fluoroquinolone resistant 51 methylenetetrahydrofolate reductase 51 QTLs 51 chronic HBV infection 51 BRCA1 mutation carriers 51 ancestries 51 thyroglobulin 51 paternal lineages 51 achieved sustained virological 51 TGFBR1 * 6A 51 cisplatin resistant 51 histone modification 51 Resource Exchange AGRE 51 gastric carcinoma 51 activating mutations 51 chromosomal anomalies 51 diploid genome 51 genotype 1b 50 chromosome #p#.# 50 multivariate analyzes 50 hypervariable 50 Framingham Offspring Study 50 oral squamous cell 50 isotype 50 serum concentrations 50 EoE 50 Li Fraumeni syndrome 50 univariate analysis 50 mutated gene 50 poor metabolizers 50 liver metastases 50 Alu elements 50 micro RNA 50 passaged 50 #S rRNA genes 50 obstructive coronary artery 50 IgM 50 CYP#C# [001] 50 PFGE 50 INF2 50 tissue transglutaminase 50 TRAIL R1 50 relapsed MM 50 genetically homogeneous 50 DRD2 gene 50 bacterial genomes 50 pg mL 50 HBeAg 50 hierarchical clustering 50 viral tropism 50 haptoglobin 50 quantitative trait loci 50 gene mutations 50 H#K#me# 50 MHC dissimilar 50 Caucasians 50 siRNAs targeting 50 ELISPOT 50 randomized 50 retrospective cohort study 50 carcinoembryonic antigen 50 Illumina GoldenGate 50 karyotypes 50 LRAT 50 RFLP 50 fraternal twin pairs 50 EORTC 50 Neandertal DNA 50 BRIP1 50 APOE allele 50 human leukocyte antigen HLA 50 susceptibility locus 50 daily subcutaneous injections 50 histologically proven 50 BRCA2 gene 50 perilipin 50 FMR1 gene 50 array CGH 50 diabetes mellitus DM 50 #q#.# deletion syndrome 50 cDNAs 50 familial aggregation 50 #p#.# [002] 50 Immunohistochemical staining 50 immunochemical 50 CFTR gene 50 clinicopathological 50 MSH6 50 asymptomatic 50 antibody titer 50 SLITRK1 50 CDK4 50 microbiologically evaluable 50 overexpressed 50 Human Leukocyte Antigen 50 kilobases 50 human leukocyte antigens 50 PBMCs 50 gallstone disease 50 Recurrence Score 50 JAK2 50 Alleles 50 coding sequences 50 gene sequences 50 Single Nucleotide Polymorphisms SNPs 50 SWOG 50 flutamide 50 Fragile X gene 50 plasma adiponectin 50 APOE4 50 PROVE IT 50 gastric adenocarcinoma 50 CYP#D# genotype 50 NMIBC 50 Epstein Barr virus EBV 50 Clusterin 50 CARDIA 50 pathogenic mutations 50 NF1 gene 50 PCR assay 50 NR#A# gene 50 P. falciparum 50 NS5B 50 HapMap 50 mammalian genome 50 #S rDNA 50 comparative genomic hybridization 50 serum selenium 50 antiretroviral naïve 50 nonpsychotic 50 HumanHap# BeadChip 50 plasma pharmacokinetics 50 Meckel Gruber 50 valine 50 biochemical relapse 50 renal cell carcinomas 50 rhesus 50 exome sequencing 50 T#I [002] 50 homologous 50 subcellular localization 50 TIMP 1 50 acid phosphatase PAP 50 HER2/neu 50 EGFR mutation 50 Kruskal Wallis test 50 mosaicism 50 phylogenetic analysis 50 CpG 50 pilocytic astrocytomas 50 promoter hypermethylation 50 heavily pretreated 50 T1DM 50 synthases 50 impaired glucose tolerance 50 mg kg dose 50 lupus anticoagulant 50 intergenic regions 50 bisulfite sequencing 50 histological subtype 50 SLC#A# [002] 50 tumor biopsies 50 serum lipid levels 50 virological failure 50 Leptospira 50 karyotype 50 PROSTVAC VF 50 acute lymphoid leukemia 50 transiently transfected 50 chromosomal aberrations 50 morphologic 50 mitochondrial DNA sequences 50 thyrotropin levels 50 FTO gene 50 C#T [002] 50 Homozygous 50 histone H4 50 APOE4 gene 50 Squamous 50 inherited maternally 50 C#Y mutation 50 idiopathic myelofibrosis 50 immunotoxin 50 V#F mutation 50 CD8 + 50 anti JCV antibodies 50 prognostic biomarker 50 elevated triglyceride levels 50 HLA DRB1 SE 50 chromosome rearrangements 50 leukemia CLL 50 NAT2 50 cytochrome b 50 GBM tumors 50 catechol O methyltransferase COMT 50 cytokeratin 50 dizygotic twins 50 androgen receptor gene 50 ovarian endometrial 50 antiretroviral naive 50 idiopathic PAH 50 LRRK2 mutation 50 virological response 50 ug dose 50 S#A# [002] 50 clades 50 atopic asthma 50 serum leptin 50 germline 50 multivariable analysis 50 haplotype map 50 Arabidopsis genome 50 MC4R gene 50 prognostic markers 50 ERalpha 50 C. trachomatis 50 PTEN gene 50 T1D 50 ALK mutations 50 treatment naïve genotype 50 metaplasia 50 kbp 50 diploid 50 herpesviruses 50 HG PIN 50 inbreeding coefficient 50 transgene expression 50 dapagliflozin plus 50 susceptibility gene 50 FGFR2 50 phenotypic characteristics 50 transcriptional profiling 49 enteroviral 49 PITX2 49 malignant lymphoma 49 hypogonadal 49 de novo AML 49 prostate cancer PCa 49 autoantibody 49 kaempferol 49 studies GWAS 49 hyper IgE syndrome 49 cDNA 49 YKL 49 tissue microarray 49 clinicopathologic 49 KIF6 gene variant 49 autoantibody positive 49 stage IIIB 49 paramyxoviruses 49 SPINK1 49 HER2 neu 49 spontaneous mutations 49 immunoglobulin G 49 subpopulations 49 carotid plaque 49 liver transplant recipients 49 highest tertile 49 PDGFRA 49 intron 49 succinate dehydrogenase 49 VeraTag studies 49 squamous cell lung cancer 49 multicentre randomized 49 virulence genes 49 atopic 49 cytopathic 49 HER2 homodimer levels 49 IGFBP 49 RNA Seq 49 fasting insulin 49 Pharmacokinetics PK 49 cell lysate 49 gene predisposing 49 K ras gene 49 lactate dehydrogenase 49 cystatin 49 genetic polymorphism 49 tryptase 49 gibbon ape 49 CALGB 49 OPRM1 gene 49 IgG antibody 49 noninfected 49 miRNAs 49 genes BRCA1 49 pigtail macaques 49 urothelial carcinoma 49 mtDNA mutations 49 Yamanaka recipe 49 epithelial tumors 49 Wistar rats 49 gene expression profiling 49 causal variants 49 multigenic 49 reverse transcriptase inhibitors 49 reaction RT PCR 49 colonic mucosa 49 Mus musculus 49 HER2 positive cancers 49 prognostic marker 49 independent prognostic marker 49 odorant receptor 49 susceptibility genes 49 CD# + [002] 49 cyclin E 49 distantly related species 49 Swedish Mammography Cohort 49 adipogenic 49 aneuploid 49 5q 49 HIV RNA 49 lymphoid malignancies 49 IDH1 mutation 49 prospectively defined 49 LTBI 49 protein encoded 49 lipoprotein associated phospholipase 49 Plasmodium falciparum 49 db db mice 49 whole genome genotyping 49 ApoE4 49 protein kinases 49 HCV infection 49 NPY gene 49 HRCT 49 autoantibodies 49 CD# + [001] 49 MLL2 49 microRNA miR 49 immunohistochemistry IHC 49 gastric carcinogenesis 49 % CI #.#-#.# [003] 49 isogenic 49 haplotyping 49 CGG repeats 49 microarray 49 CYP#C# * 49 ASCUS 49 DRB1 * 49 microalbumin 49 S. enterica 49 CNTNAP2 49 SCN1A 49 amnestic MCI 49 lymphoproliferative 49 longitudinal cohort study 49 prevalences 49 KRAS BRAF 49 suppressor gene 49 copies ml 49 Epigenomics proprietary 49 HLA gene variant 49 causative gene 49 methyltransferase 49 WT1 49 Baseline characteristics 49 mice lacking 49 Heterozygous 49 parkin gene 49 diagnostic biomarker 49 X. tropicalis 49 Nutrition EPIC 49 atherosclerotic lesions 49 transcriptional profiles 49 Lp PLA2 49 leukocyte count 49 MTHFR gene 49 inhibin B 49 HCV genotypes 49 lung adenocarcinomas 49 overexpressing 49 undergone hysterectomies 49 microarray datasets 49 T1c 49 epithelial ovarian cancer 49 gene BRCA2 49 genetic locus 49 Gene Expression Assays 49 MGUS 49 Matthew Hurles 49 RefSeq 49 pCR 49 rRNA 49 % CI #.#-#.# [006] 49 siRNA knockdown 49 CD#c 49 ovarian pancreatic 49 murine leukemia virus 49 chromosomal abnormalities 49 prepubertal 49 epitope 49 dopamine receptor gene 49 HFE gene 49 leukotriene B4 49 Li Fraumeni 49 serotype 49 GABRA2 49 cytologically confirmed 49 MDR1 49 metastatic malignant 49 NKX#.# 49 lowest tertile 49 transcriptional regulator 49 adenoviral 49 ovarian carcinoma 49 evaluable 49 EGFRvIII 49 Y chromosomes 49 ApoE4 allele 49 TEL AML1 49 BVDV 49 genetic variability 49 dosing cohort 49 cells uL 49 AGTR1 49 latent celiac disease 49 CD# CD# 49 predictive biomarker 49 SLC#A# [001] 49 Ovarian Cancer Screening 49 admixed populations 49 % CI #.#-#.# [007] 49 promoter polymorphism 49 ± SD 49 granulocyte 49 histologies 49 polyploid 49 maternal serum 49 KRAS gene 49 ApoE